These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3579005)
1. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group. Di Lorenzo G; Morici G; Drago A; Pellitteri ME; Mansueto P; Melluso M; Norrito F; Squassante L; Fasolo A Clin Ther; 1998; 20(6):1130-48. PubMed ID: 9916607 [TBL] [Abstract][Full Text] [Related]
4. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Thomas P; Pugsley JA; Stewart JH Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064 [TBL] [Abstract][Full Text] [Related]
5. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease. Filuk RB; Easton PA; Anthonisen NR Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322 [TBL] [Abstract][Full Text] [Related]
6. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C; Testi R; Polese G; Tosatto R; Rossi A Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852 [TBL] [Abstract][Full Text] [Related]
7. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD? Nishimura K; Koyama H; Ikeda A; Izumi T Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065 [TBL] [Abstract][Full Text] [Related]
9. [Response to inhaled bronchodilators in chronic airway obstruction]. Holten K Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284 [TBL] [Abstract][Full Text] [Related]
10. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Man GC; Champman KR; Ali SH; Darke AC Chest; 1996 Sep; 110(3):648-53. PubMed ID: 8797406 [TBL] [Abstract][Full Text] [Related]
11. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Belman MJ; Botnick WC; Shin JW Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581 [TBL] [Abstract][Full Text] [Related]
13. The role of domiciliary nebulizers in managing patients with severe COPD. Eiser N; Angus K; McHale S Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108 [TBL] [Abstract][Full Text] [Related]
14. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Guyatt GH; Townsend M; Nogradi S; Pugsley SO; Keller JL; Newhouse MT Arch Intern Med; 1988 Sep; 148(9):1949-52. PubMed ID: 3046537 [TBL] [Abstract][Full Text] [Related]
15. Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD. Cazzola M; Noschese P; Centanni S; Santus P; Di Marco F; Spicuzza L; Di Maria GU Pulm Pharmacol Ther; 2004; 17(3):141-5. PubMed ID: 15123223 [TBL] [Abstract][Full Text] [Related]
16. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Mahon JL; Laupacis A; Hodder RV; McKim DA; Paterson NA; Wood TE; Donner A Chest; 1999 Jan; 115(1):38-48. PubMed ID: 9925061 [TBL] [Abstract][Full Text] [Related]
17. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial. Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466 [TBL] [Abstract][Full Text] [Related]
18. Oral doxophylline in patients with chronic obstructive pulmonary disease. Villani F; De Maria P; Ronchi E; Galimberti M Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999 [TBL] [Abstract][Full Text] [Related]
19. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Guyatt GH; Townsend M; Keller J; Singer J; Nogradi S Respir Med; 1989 Jul; 83(4):293-7. PubMed ID: 2692093 [TBL] [Abstract][Full Text] [Related]
20. [Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD]. Dreyse J; Silva F; Díaz O; Borzone G; Lisboa C Rev Med Chil; 2005 Oct; 133(10):1211-9. PubMed ID: 16341372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]